Bank of New York Mellon’s PMV Pharmaceuticals PMVP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-117,101
| Closed | -$199K | – | 4221 |
|
|
2024
Q1 | $199K | Sell |
117,101
-8,386
| -7% | -$14.3K | ﹤0.01% | 3928 |
|
|
2023
Q4 | $389K | Buy |
125,487
+997
| +0.8% | +$3.09K | ﹤0.01% | 3690 |
|
|
2023
Q3 | $764K | Sell |
124,490
-248
| -0.2% | -$1.52K | ﹤0.01% | 3324 |
|
|
2023
Q2 | $781K | Buy |
124,738
+2,218
| +2% | +$13.9K | ﹤0.01% | 3342 |
|
|
2023
Q1 | $584K | Sell |
122,520
-279
| -0.2% | -$1.33K | ﹤0.01% | 3412 |
|
|
2022
Q4 | $1.07M | Buy |
122,799
+346
| +0.3% | +$3.01K | ﹤0.01% | 3160 |
|
|
2022
Q3 | $1.46M | Buy |
122,453
+17,776
| +17% | +$212K | ﹤0.01% | 3026 |
|
|
2022
Q2 | $1.49M | Buy |
104,677
+24,528
| +31% | +$350K | ﹤0.01% | 2996 |
|
|
2022
Q1 | $1.67M | Sell |
80,149
-214
| -0.3% | -$4.46K | ﹤0.01% | 3033 |
|
|
2021
Q4 | $1.86M | Buy |
80,363
+2,987
| +4% | +$69K | ﹤0.01% | 3036 |
|
|
2021
Q3 | $2.31M | Buy |
77,376
+11,666
| +18% | +$348K | ﹤0.01% | 2899 |
|
|
2021
Q2 | $2.24M | Buy |
65,710
+25,297
| +63% | +$864K | ﹤0.01% | 2910 |
|
|
2021
Q1 | $1.33M | Sell |
40,413
-881
| -2% | -$29K | ﹤0.01% | 3171 |
|
|
2020
Q4 | $2.54M | Buy |
+41,294
| New | +$2.54M | ﹤0.01% | 2701 |
|